Searched over 200M research papers
10 papers analyzed
These studies suggest that early and accurate diagnosis, adherence to evidence-based guidelines, and innovative detection methods are crucial for improving outcomes in atrial fibrillation patients.
20 papers analyzed
Atrial fibrillation (AFib) is the most common sustained cardiac arrhythmia, characterized by irregular and often rapid heartbeats. This condition significantly increases the risk of stroke, heart failure, and mortality . Early diagnosis and adherence to treatment guidelines are crucial for improving patient outcomes.
Adherence to evidence-based guidelines is essential in managing AFib effectively. The "Get With The Guidelines-AFIB" initiative aims to improve adherence to these guidelines through a hospital-based performance improvement program. This initiative focuses on enhancing anticoagulation therapy, heart rate control, safe antiarrhythmic drug use, and patient education. Despite the availability of these guidelines, adherence remains low, highlighting the need for continuous quality improvement efforts.
Several factors influence the diagnosis and treatment of AFib, including age, gender, heart failure history, and underlying coronary artery disease (CAD) or acute coronary syndrome (ACS). Notably, the elderly population is less likely to receive anticoagulation therapy, with only about one-third of eligible elderly patients being prescribed this treatment. The CHADS2 and CHA2DS2-VASc scoring systems are critical tools for assessing stroke risk in AFib patients, with the latter providing a more sensitive risk stratification.
In sub-Saharan Africa, heart failure (HF) is a significant non-communicable disease affecting young and economically active adults. AFib is a major determinant of mortality among HF patients in this region. However, the use of anti-arrhythmic medications remains low, necessitating a systematic review to evaluate the prevalence, incidence, and mortality rates associated with AFib in HF patients.
Recent advancements in technology have enabled the use of smartphone-derived seismocardiography (SCG) and gyrocardiography (GCG) signals for the automated detection of AFib. Studies have shown that these methods can achieve high accuracy, sensitivity, and specificity, making them viable options for self-monitoring and early diagnosis.
Deep learning techniques, such as the AfibPred approach, utilize pretrained models to analyze short single-lead ECG signals for AFib detection. This method has demonstrated high accuracy and F1 scores, proving its effectiveness in early diagnosis and management of AFib. Additionally, the use of photoplethysmography (PPG) signals from smartphone cameras has been explored, offering a cost-effective and accessible method for continuous AFib monitoring.
Right ventricular dysfunction (RVD) is a strong predictor of AFib development in patients with acute decompensated heart failure (ADHF). Patients with both AFib and RVD have worse outcomes, including higher rates of cardiac readmission and mortality. Evaluating RV function can help stratify risk and improve prognosis in these patients.
Emerging research indicates that liver disease is a risk factor for AFib. The pathophysiology involves atrial distension, abnormal conduction, catecholamine excess, and increased atrial irritation. Understanding this connection can help in developing clinical interventions to prevent AFib aggravation in patients with liver disease.
Atrial fibrillation is a prevalent and serious cardiac arrhythmia with significant implications for patient health. Adherence to treatment guidelines, early diagnosis through advanced technologies, and understanding risk factors are crucial for effective management. Continuous efforts in quality improvement, technological innovation, and comprehensive risk assessment are essential to improve outcomes for AFib patients.
Most relevant research papers on this topic